Venmax Drugs & Pharmaceuticals Ltd Share Price
As on 18 November 2025 at 23:47 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
17.89%
Over 6 Months
7.26%
Over 1 Year
355.78%
Over 3 Years
None%
Venmax Drugs & Pharmaceuticals Ltd Summary
Close ₹29.99
Open ₹28.99
High ₹30.24
Low ₹28.59
Volume 55
Net Turnover (in Cr) ₹0.00016
52Wk High ₹36.96
52Wk Low ₹6.27
52Wk High / Low
6.27
36.96
Venmax Drugs & Pharmaceuticals Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹15.71
EPS (TTM) 0.66
Book Value (BV) 11.09
Div. Yield -
P/E (TTM) 45.44
Price/Book Value 2.71
Delivery % 100 %
Face Value 10
Key Ratios
PE Ratio -
PB Ratio -22.63
EV to Sales 15.44
PEG Ratio -
ROA -0.22
ROE -
Debt-Equity 0.11
Net Profit Margin 14.81
Operating Profit Margin 14.81
Venmax Drugs & Pharmaceuticals Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1.86 | 0.20 | 0.42 | 1.98 | 0.35 |
| Total Expenses | 1.87 | 0.11 | 0.19 | 0.14 | 0.51 |
| Profit Before Tax | -0.01 | 0.09 | 0.23 | 1.85 | -0.16 |
| Profit After Tax | -0.01 | 0.06 | 0.23 | 1.85 | -0.16 |
| Operating Profit After Depreciation | -0.01 | 0.09 | 0.23 | 1.85 | -0.16 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 0.04 | 0.07 | 0.07 | 0.08 | 0.09 |
| Total Non Current Assets | 0.04 | 0.07 | 0.07 | 0.08 | 0.09 |
| Total Current Assets | 5.13 | 0.02 | 0.14 | 0.13 | 0.22 |
| Total Assets | 5.17 | 0.08 | 0.21 | 0.21 | 0.31 |
| Total Shareholder's Fund | 4.41 | -0.65 | -0.71 | -0.94 | -2.79 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -2.29 | - | - | 1.91 | 0.26 |
| Net Cash Used In Investing Activities | - | - | - | - | - |
| Net Cash Used In Financing Activities | 4.77 | - | - | -1.98 | -0.19 |
No data available
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 1.32 | 1.21 | 0.33 | 0.20 | 0.17 |
| Total Expenses | 1.27 | 1.17 | 0.58 | 0.69 | 0.47 |
| Profit Before Tax | 0.05 | 0.04 | 0.77 | -0.49 | -0.30 |
| Profit After Tax | 0.02 | 0.04 | 0.78 | -0.50 | -0.30 |
| Operating Profit after Depreciation | 0.05 | 0.04 | 0.77 | -0.49 | -0.30 |
Venmax Drugs & Pharmaceuticals Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 28.97
S2 27.96
S3 27.32
Pivot 29.61
R1 30.62
R2 31.26
R3 32.27
Moving Average
20 SMA 28.03
50 SMA 25.65
100 SMA 26.48
200 SMA 26.40
Venmax Drugs & Pharmaceuticals Ltd Corporate Actions
No available data
Venmax Drugs & Pharmaceuticals Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Venmax Drugs & Pharmaceuticals Ltd Top Mutal Funds Invested
No data available
Venmax Drugs & Pharmaceuticals Ltd News
Venmax Drugs & Pharmaceuticals to discuss results
On 12 November 2025
06 Nov 2025, 12:34 pm
Venmax Drugs & Pharmaceuticals to convene AGM
On 27 September 2025
09 Sep 2025, 05:54 pm
Venmax Drugs & Pharmaceuticals schedules board meeting
On 2 September 2025
25 Aug 2025, 05:37 pm
Venmax Drugs & Pharmaceuticals to conduct board meeting
On 16 August 2025
11 Aug 2025, 10:03 am
Venmax Drugs & Pharmaceuticals to declare Quarterly Results
On 23 July 2025
16 Jul 2025, 05:26 pm
Venmax Drugs & Pharmaceuticals Ltd Stock Analysis
- Annual revenue for Venmax Drugs & Pharmaceuticals Ltd increased by 836.81% to ₹1.86 crore in FY 2025 from ₹0.20 crore in FY 2024.
- Annual Net Profit for Venmax Drugs & Pharmaceuticals Ltd decreased by 116.28% to ₹-0.01 crore in FY 2025 from ₹0.06 crore in FY 2024.
- Promoter Shareholding in Venmax Drugs & Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 23.14% in June 2025 to 23.14% in September 2025.
- Venmax Drugs & Pharmaceuticals Ltd delivered a 1-year return of 355.78% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Venmax Drugs & Pharmaceuticals Ltd share price moved up by 3.17% from its previous close of INR ₹29.99. The latest Venmax Drugs & Pharmaceuticals Ltd share price is INR ₹30.94.
- Venmax Drugs & Pharmaceuticals Ltd share price today has been at a low of 29.99 and a high of 31.45. Over the past 52 weeks, the Venmax Drugs & Pharmaceuticals Ltd share price has seen a low of 6.27 and a high of 36.96.
FAQ’s
What is the share price of Venmax Drugs & Pharmaceuticals Ltd today?
Venmax Drugs & Pharmaceuticals Ltd share price as on 18 Nov 2025 is ₹ 30.94
What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd?
The market cap of Venmax Drugs & Pharmaceuticals Ltd stock is ₹15.71 Cr.
What is the PE Ratio of Venmax Drugs & Pharmaceuticals Ltd?
The Price to Earnings (P/E) Ratio of Venmax Drugs & Pharmaceuticals Ltd is -
What is the PB Ratio of Venmax Drugs & Pharmaceuticals Ltd?
The Price to Book (P/B) Ratio of Venmax Drugs & Pharmaceuticals Ltd is -22.63
What is the 52 week high of Venmax Drugs & Pharmaceuticals Ltd Share Price?
The 52 week high of Venmax Drugs & Pharmaceuticals Ltd share price stands at ₹36.96
What is the 52 week low of Venmax Drugs & Pharmaceuticals Ltd Share Price?
The 52 week low of Venmax Drugs & Pharmaceuticals Ltd share price stands at ₹6.27
How can I buy shares of Venmax Drugs & Pharmaceuticals Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Venmax Drugs & Pharmaceuticals Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
